Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest Expenses (2017 - 2026)

Organogenesis Holdings has reported Interest Expenses over the past 9 years, most recently at -$236000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 286.89% year-over-year to -$236000.0; the TTM value through Dec 2025 reached -$2.3 million, down 247.73%, while the annual FY2025 figure was -$2.3 million, 247.73% down from the prior year.
  • Interest Expenses for Q4 2025 was -$236000.0 at Organogenesis Holdings, up from -$415000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $2.5 million in Q1 2021 and troughed at -$961000.0 in Q1 2025.
  • A 5-year average of $534850.0 and a median of $543000.0 in 2022 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: skyrocketed 1773.33% in 2023 and later tumbled 286.96% in 2025.
  • Year by year, Interest Expenses stood at $853000.0 in 2021, then plummeted by 103.52% to -$30000.0 in 2022, then skyrocketed by 1773.33% to $502000.0 in 2023, then tumbled by 112.15% to -$61000.0 in 2024, then crashed by 286.89% to -$236000.0 in 2025.
  • Business Quant data shows Interest Expenses for ORGO at -$236000.0 in Q4 2025, -$415000.0 in Q3 2025, and -$669000.0 in Q2 2025.